Exparel 266 MG/20 ML vial 20ML
Ended Awarded Last action
- Contract number
- SPE2DR26FSCD6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,673
Award facts
- Contract value 100% obligated
- $25,673.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,673.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. The delivery order was issued on January 14, 2026, with an ultimate completion date of February 5, 2026, and does not utilize a set-aside designation. This award represents a single transaction under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
DMS Pharmaceutical Group holds a single-award IDC under the PPV-G GEN V program with a $499.999 billion ceiling value extending through December 31, 2036. This program represents the Department of Defense's comprehensive pharmaceutical supply strategy, enabling the Defense Logistics Agency to issue firm fixed-price delivery orders for branded and generic pharmaceuticals, biologics, and medical consumables to support military healthcare facilities worldwide. As one of multiple regional prime vendor contractors within this $30.3 billion acquisition strategy, DMS Pharmaceutical Group has demonstrated consistent performance across diverse product categories including specialty surgical products such as EXPAREL, positioning the company as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FSCD6?
SPE2DR26FSCD6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FSCD6 worth?
The government has obligated $25,673 on SPE2DR26FSCD6.
Is contract SPE2DR26FSCD6 an order under another contract?
Yes. SPE2DR26FSCD6 is a delivery order under SPE2DR25D9316, an indefinite delivery contract.
Was contract SPE2DR26FSCD6 competed?
The extent of competition for SPE2DR26FSCD6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award